All In MedTech

Device Trial Radar · NCT07525518

Okami Medical ALPHA Registry

Okami Medical Comprehensive Registry Platform

Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

500

Planned (sponsor's estimate)

Start

Mar 31, 2026

Primary completion

Aug 2030

Study completion Aug 2030

Sponsor

Lead sponsor
Okami Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Apr 13, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This registry will provide insights into the use of Okami Medical devices in real-world clinical and study effectiveness and safety of Okami Medical devices.

Conditions

  • Arterial Bleed
  • Pulmonary Arteriovenous Malformation
  • Embolization
  • Hemorrhage

Interventions

  • LOBO Vascular Occlusion SystemDevice

    LOBO Vascular Occlusion System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety EndpointTime frame: 30 days post-index procedure

1 more outcomes with a free account

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Stanford University

    Stanford, California

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.